Prescription en ligne
Prescription en ligne is a medical utility for ART patients to access prescriptions and track treatment schedules on iOS.
The App DNA
What makes this app unique?
The app removes the friction of manual paper-based tracking by syncing directly with clinic EMR data, ensuring patients follow complex stimulation protocols accurately.
For Patients undergoing Assisted Reproduction Technology (ART) treatment at clinics using MediFirst software.
What does it look like?
Key features
Direct retrieval of ART stimulation prescriptions transmitted by medical centers.
Visual timeline of upcoming medical appointments and medication schedules.
Push notifications and alarms for medication adherence and appointment reminders.
How much does it cost?
The app operates as a free utility, functioning as a distribution channel for the developer's B2B EMR software.
Velocity
Dormant developmentShow more...
Prescription en ligne has seen no development activity for 334 days. With only a single version release in the observed window, the app is currently in a state of total stagnation. There is no evidence of ongoing maintenance, feature updates, or operational support.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Prescription en ligne
How's the Medical market?
Prescription en ligne maintains a niche position in the Medical category, ranking #108 Free in France and #99 in Belgium. The lack of recent updates and public review volume confirms its status as a closed-loop B2B utility rather than a mass-market competitor.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Prescription en ligne
Where is it heading?
The market for clinic-integrated medical utilities is consolidating around EMR-native solutions that offer deeper patient-provider connectivity. Prescription en ligne remains advantaged by its direct link to MediFirst, but the lack of recent development leaves it vulnerable to more agile, EMR-agnostic fertility platforms.
- The 11-month update gap indicates a mature, maintenance-only product lifecycle that prioritizes stability over feature expansion.
- Closed-loop distribution via clinic credentials limits growth but ensures a highly qualified, low-churn user base.
The SWOT
- Direct EMR integration removes manual patient entry
- Credential-gated access ensures patient data privacy
- Specialized calendar interface tracks complex ART protocols
- Lab result visualization could increase daily utility
- Non-ART medication reminders could broaden user base
Next best moves
Audit EMR sync stability because no updates have shipped in 11 months → prevent data-loss risk
The counter-intuitive read
The lack of public reviews is a feature, not a bug…
Read the full takeSince the last report: The app's competitive positioning has shifted from a focus on development stagnation to a formal recognition of its role as a stable, closed-loop B2B utility. This pivot clarifies that the lack of updates is a byproduct of its EMR-integrated, credential-gated architecture rather than a failure of maintenance.
Bottom line
Prescription en ligne functions as a stable, clinic-integrated utility that prioritizes patient adherence over consumer growth. Maintaining this EMR-sync reliability is the primary lever for retaining the existing clinic-affiliated user base.
Unlock 3 critical frictions, 2 market threats and the analyst’s take.
Access the full report for freeSources
- [1] Play Store listing
Report last updated